Pfizer and BioNTech Receive US Emergency Use Authorisation of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Booste

Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) granted emergency use authorisation (EUA) to provide a single booster dose of the companies